tiprankstipranks
Reata Pharmaceuticals (RETA)
NASDAQ:RETA

Reata Pharmaceuticals (RETA) Ownership - Who Owns Reata Pharmaceuticals?

453 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 18, 2023
Andrea Loewen
Svp, Global Regulatory Affairs
Sold$546164
Sep 07, 2023
Anand Bhaskar
Svp & Cao
Sold$68695
Aug 17, 2023
Anand Bhaskar
Svp & Cao
Sold$67993
Aug 17, 2023
Manmeet Singh Soni
Coo, Cfo And President
Sold$295560

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2023Sold$261017
Jun 30, 2023Sold$1019600
Jun 30, 2023Bought$9680592
Jun 30, 2023Bought$20912811

Top Shareholders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,382Institution0.03%241,834
66Institution<0.01%6,729
66Institution<0.01%6,729

FAQ

Who Owns Reata Pharmaceuticals (RETA)?
Currently, no data Available
What percentage of Reata Pharmaceuticals (RETA) stock is held by institutional investors?
Currently, no data Available
What percentage of Reata Pharmaceuticals (RETA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Reata Pharmaceuticals (RETA)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis